Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA388517
Max Phase: Preclinical
Molecular Formula: C14H9BrClNO4
Molecular Weight: 370.59
Molecule Type: Small molecule
Associated Items:
ID: ALA388517
Max Phase: Preclinical
Molecular Formula: C14H9BrClNO4
Molecular Weight: 370.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(Nc1cccc(Br)c1)Oc1cc(Cl)ccc1C(=O)O
Standard InChI: InChI=1S/C14H9BrClNO4/c15-8-2-1-3-10(6-8)17-14(20)21-12-7-9(16)4-5-11(12)13(18)19/h1-7H,(H,17,20)(H,18,19)
Standard InChI Key: AQVHUBROHKHLRM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 370.59 | Molecular Weight (Monoisotopic): 368.9403 | AlogP: 4.41 | #Rotatable Bonds: 3 |
Polar Surface Area: 75.63 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.38 | CX Basic pKa: | CX LogP: 4.52 | CX LogD: 1.11 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.84 | Np Likeness Score: -1.27 |
1. Valgeirsson J, Nielsen EO, Peters D, Mathiesen C, Kristensen AS, Madsen U.. (2004) Bioisosteric modifications of 2-arylureidobenzoic acids: selective noncompetitive antagonists for the homomeric kainate receptor subtype GluR5., 47 (27): [PMID:15615543] [10.1021/jm030638w] |
Source(1):